Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy
Akihiro Asai, Nita Sahani, Masao Kaneki, Yasuyoshi Ouchi, J A Jeevendra Martyn, Shingo Egusa Yasuhara, Akihiro Asai, Nita Sahani, Masao Kaneki, Yasuyoshi Ouchi, J A Jeevendra Martyn, Shingo Egusa Yasuhara
Abstract
Background: Duchenne Muscular Dystrophy (DMD) is characterized by increased muscle damage and an abnormal blood flow after muscle contraction: the state of functional ischemia. Until now, however, the cause-effect relationship between the pathogenesis of DMD and functional ischemia was unclear. We examined (i) whether functional ischemia is necessary to cause contraction-induced myofiber damage and (ii) whether functional ischemia alone is sufficient to induce the damage.
Methodology/principal findings: In vivo microscopy was used to document assays developed to measure intramuscular red blood cell flux, to quantify the amount of vasodilatory molecules produced from myofibers, and to determine the extent of myofiber damage. Reversal of functional ischemia via pharmacological manipulation prevented contraction-induced myofiber damage in mdx mice, the murine equivalent of DMD. This result indicates that functional ischemia is required for, and thus an essential cause of, muscle damage in mdx mice. Next, to determine whether functional ischemia alone is enough to explain the disease, the extent of ischemia and the amount of myofiber damage were compared both in control and mdx mice. In control mice, functional ischemia alone was found insufficient to cause a similar degree of myofiber damage observed in mdx mice. Additional mechanisms are likely contributing to cause more severe myofiber damage in mdx mice, suggestive of the existence of a "two-hit" mechanism in the pathogenesis of this disease.
Conclusions/significance: Evidence was provided supporting the essential role of functional ischemia in contraction-induced myofiber damage in mdx mice. Furthermore, the first quantitative evidence for the "two-hit" mechanism in this disease was documented. Significantly, the vasoactive drug tadalafil, a phosphodiesterase 5 inhibitor, administered to mdx mice ameliorated muscle damage.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Hoffman EP, Kunkel LM. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron. 1989;2:1019–1029.
- Emery AE. Population frequencies of inherited neuromuscular diseases–a world survey. Neuromuscul Disord. 1991;1:19–29.
- Petrof BJ. The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Mol Cell Biochem. 1998;179:111–123.
- Sander M, Chavoshan B, Harris SA, Iannaccone ST, Stull JT, et al. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A. 2000;97:13818–13823.
- Thomas GD, Sander M, Lau KS, Huang PL, Stull JT, et al. Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci U S A. 1998;95:15090–15095.
- Corcondilas A, Koroxenidis GT, Shepherd JT. Effect Of A Brief Contraction Of Forearm Muscles On Forearm Blood Flow. J Appl Physiol. 1964;19:142–146.
- Mendell JR, Engel WK, Derrer EC. Duchenne muscular dystrophy: functional ischemia reproduces its characteristic lesions. Science. 1971;172:1143–1145.
- Lau KS, Grange RW, Isotani E, Sarelius IH, Kamm KE, et al. nNOS and eNOS modulate cGMP formation and vascular response in contracting fast-twitch skeletal muscle. Physiol Genomics. 2000;2:21–27.
- Stamler JS, Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev. 2001;81:209–237.
- Lau KS, Grange RW, Chang WJ, Kamm KE, Sarelius I, et al. Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide. FEBS Lett. 1998;431:71–74.
- Burbach JA. Ultrastructure of cardiocyte degeneration and myocardial calcification in the dystrophic hamster. Am J Anat. 1987;179:291–307.
- Engel WK. Nouvelle hypothese sur la pathogenie de la dystrophie musculaire pseudo-hypertrophique de Duchenne. Revue Neurologique (Paris) 1971;124:291–298.
- Jerusalem F, Engel AG, Gomez MR. Duchenne dystrophy. I. Morphometric study of the muscle microvasculature. Brain. 1974;97:115–122.
- Kobayashi Y, Suzuki H, Iinuma K, Tada K, Yamamoto TY. Endothelial alterations of skeletal muscle capillaries in childhood myopathies. Tohoku J Exp Med. 1983;140:381–389.
- Miike T, Sugino S, Ohtani Y, Taku K, Yoshioka K. Vascular endothelial cell injury and platelet embolism in Duchenne muscular dystrophy at the preclinical stage. J Neurol Sci. 1987;82:67–80.
- Musch BC, Papapetropoulos TA, McQueen DA, Hudgson P, Weightman D. A comparison of the structure of small blood vessels in normal, denervated and dystrophic human muscle. J Neurol Sci. 1975;26:221–234.
- Hunter EG, Elbrink J. Increased contractility in vascular smooth muscle of dystrophic hamsters. Can J Physiol Pharmacol. 1983;61:182–185.
- Miyatake M, Miike T, Zhao J, Yoshioka K, Uchino M, et al. Possible systemic smooth muscle layer dysfunction due to a deficiency of dystrophin in Duchenne muscular dystrophy. J Neurol Sci. 1989;93:11–17.
- Chao DS, Silvagno F, Bredt DS. Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase. J Neurochem. 1998;71:784–789.
- Crosbie RH, Straub V, Yun HY, Lee JC, Rafael JA, et al. mdx muscle pathology is independent of nNOS perturbation. Hum Mol Genet. 1998;7:823–829.
- Komori K, Vanhoutte PM. Endothelium-derived hyperpolarizing factor. Blood Vessels. 1990;27:238–245.
- Morikawa K, Shimokawa H, Matoba T, Kubota H, Akaike T, et al. Pivotal role of Cu,Zn-superoxide dismutase in endothelium-dependent hyperpolarization. J Clin Invest. 2003;112:1871–1879.
- Rando TA. Role of nitric oxide in the pathogenesis of muscular dystrophies: a “two hit” hypothesis of the cause of muscle necrosis. Microsc Res Tech. 2001;55:223–235.
- Tsai AG, Intaglietta M. Local tissue oxygenation during constant red blood cell flux: a discrete source analysis of velocity and hematocrit changes. Microvasc Res. 1989;37:308–322.
- Kim MB, Sarelius IH. Distributions of wall shear stress in venular convergences of mouse cremaster muscle. Microcirculation. 2003;10:167–178.
- Ferreira LF, Padilla DJ, Musch TI, Poole DC. Temporal profile of rat skeletal muscle capillary haemodynamics during recovery from contractions. J Physiol. 2006;573:787–797.
- Berg BR, Sarelius IH. Erythrocyte flux in capillary networks during maturation: implications for oxygen delivery. Am J Physiol. 1996;271:H2263–2273.
- Mohr T, Akers TK, Wessman HC. Effect of high voltage stimulation on blood flow in the rat hind limb. Phys Ther. 1987;67:526–533.
- MacLeod KM, Ng DD, Harris KH, Diamond J. Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to alpha-adrenoceptor stimulation. Mol Pharmacol. 1987;32:59–64.
- Griffith TM, Edwards DH, Lewis MJ, Henderson AH. Evidence that cyclic guanosine monophosphate (cGMP) mediates endothelium-dependent relaxation. Eur J Pharmacol. 1985;112:195–202.
- Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res. 1987;61:866–879.
- Chiba S, Tsukada M. Vascular responses to beta-adrenoceptor subtype-selective agonists with and without endothelium in rat common carotid arteries. J Auton Pharmacol. 2001;21:7–13.
- Uruno A, Sugawara A, Kanatsuka H, Kagechika H, Saito A, et al. Upregulation of nitric oxide production in vascular endothelial cells by all-trans retinoic acid through the phosphoinositide 3-kinase/Akt pathway. Circulation. 2005;112:727–736.
- Doughty JM, Plane F, Langton PD. Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium. Am J Physiol. 1999;276:H1107–1112.
- White R, Hiley CR. Endothelium and cannabinoid receptor involvement in levcromakalim vasorelaxation. Eur J Pharmacol. 1997;339:157–160.
- Martensson J, Meister A. Mitochondrial damage in muscle occurs after marked depletion of glutathione and is prevented by giving glutathione monoester. Proc Natl Acad Sci U S A. 1989;86:471–475.
- Lopes-Ferreira M, Nunez J, Rucavado A, Farsky SH, Lomonte B, et al. Skeletal muscle necrosis and regeneration after injection of Thalassophryne nattereri (niquim) fish venom in mice. Int J Exp Pathol. 2001;82:55–64.
- Tidball JG, Albrecht DE, Lokensgard BE, Spencer MJ. Apoptosis precedes necrosis of dystrophin-deficient muscle. J Cell Sci. 1995;108 (Pt 6):2197–2204.
- Weller B, Karpati G, Carpenter S. Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J Neurol Sci. 1990;100:9–13.
- Bloom TJ. Cyclic nucleotide phosphodiesterase isozymes expressed in mouse skeletal muscle. Can J Physiol Pharmacol. 2002;80:1132–1135.
- Wehling M, Spencer MJ, Tidball JG. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol. 2001;155:123–131.
- Tidball JG, Wehling-Henricks M. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Mol Genet Metab. 2004;82:312–320.
- Ito K, Kimura S, Ozasa S, Matsukura M, Ikezawa M, et al. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice. Hum Mol Genet. 2006;15:2266–2275.
- Furchgott RF, WZawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373–376.
- Toda N, Ayajiki K, Okamura T. Nitric oxide and penile erectile function. Pharmacol Ther. 2005;106:233–266.
- Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell. 1995;82:743–752.
- Bia BL, Cassidy PJ, Young ME, Rafael JA, Leighton B, et al. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy. J Mol Cell Cardiol. 1999;31:1857–1862.
- Louboutin JP, Rouger K, Tinsley JM, Halldorson J, Wilson JM. iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin. Mol Med. 2001;7:355–364.
- Winston BW, Krein PM, Mowat C, Huang Y. Cytokine-induced macrophage differentiation: a tale of 2 genes. Clin Invest Med. 1999;22:236–255.
- Auwerx JH, Chait A, Wolfbauer G, Deeb SS. Loss of copper-zinc superoxide dismutase gene expression in differentiated cells of myelo-monocytic origin. Blood. 1989;74:1807–1810.
- Tomoda T, Nomura I, Kurashige T, Kubonishi I, Miyoshi I, et al. Changes in Cu,Zn-superoxide dismutase gene during induced erythroid and myeloid differentiation. Acta Haematol. 1991;86:183–188.
- Carter AB, Tephly LA, Venkataraman S, Oberley LW, Zhang Y, et al. High levels of catalase and glutathione peroxidase activity dampen H2O2 signaling in human alveolar macrophages. Am J Respir Cell Mol Biol. 2004;31:43–53.
- Edwards RJ, Watts DC, Watts RL, Rodeck CH. Creatine kinase estimation in pure fetal blood samples for the prenatal diagnosis of Duchenne muscular dystrophy. Prenat Diagn. 1984;4:267–277.
- Emery AE. Muscle histology and creatine kinase levels in the foetus in Duchenne muscular dystrophy. Nature. 1977;266:472–473.
- Eli-Lily Rat study shows tadalafil and/or its metabolite crosses placenta and secreted into milk. Eli Lily Company's Drug Information.
- Mavrogeni S, Tzelepis GE, Athanasopoulos G, Maounis T, Douskou M, et al. Cardiac and sternocleidomastoid muscle involvement in Duchenne muscular dystrophy: an MRI study. Chest. 2005;127:143–148.
- Lichtman JW, Magrassi L, Purves D. Visualization of neuromuscular junctions over periods of several months in living mice. J Neurosci. 1987;7:1215–1222.
- Strahler AN. Quantitative analysis of watershed geomorphology. Trans Am Geophys Union. 1957;38:913–920.
- Rich MM, Lichtman JW. In vivo visualization of pre- and postsynaptic changes during synapse elimination in reinnervated mouse muscle. J Neurosci. 1989;9:1781–1805.
- Matsuda R, Nishikawa A, Tanaka H. Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J Biochem (Tokyo) 1995;118:959–964.
- Tsai AG, Arfors KE, Intaglietta M. Spatial distribution of red blood cells in individual skeletal muscle capillaries during extreme hemodilution. Int J Microcirc Clin Exp. 1991;10:317–334.
Source: PubMed